← All trials
NCT05815485
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 4, 2023
- Primary completion
- Apr 30, 2026
- Completion date
- Apr 30, 2026
- First posted
- Apr 18, 2023
- Last posted
- Oct 31, 2023
- Enrollment
- 144
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MichiganLead sponsor
- University of MichiganSponsor investigator
- University of MichiganStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.